Glenmark Pharmaceuticals Inc., USA: Atomoxetine Capsules, USP, 80 mg, 30
Recall reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.. Recalled by Glenmark Pharmaceuticals Inc., USA. Distribution: Nationwide within the U.S. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot Numbers: 19233234, 19233253, Exp.: 7/2025; 19234154, Exp.: 9/2025; 19243185, Exp.: 7/2026; 19243951, 19243974, Exp.:. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report